Generics

The Afinitor brand and its generic versions had a market value of $712 million, while Saphris had a market value of $233 million, during the 12 months ended December 2020.

Mayne Pharma launched four generic contraceptive products this year. They have a combined market value of approximately $315 million for the 12 months ended January 2021, according to IQVIA.

Unichem's generic Tenex provides a treatment for the management of hypertension.

Droxidopa capsules had a market value of approximately $353 million in the 12 months ended November 2020, according to IQVIA.

Droxidopa capsules had a market value of $352 million, according to IQVIA December 2020 data.

Endo chairman Paul Campanelli is joining the Slayback Pharma board of directors.

Perrigo is selling its generic prescription business to Altaris Capital Partners for a total consideration of $1.55 billion, including $1.5 billion in cash.

The product had a market value of roughly $332 million, for the 12 months ended December 2020, according to IQVIA.